Subcutaneous hdm-ASIT+: Completed Ph IIa enrollment

ASIT completed enrollment of 37 patients in the double-blind, placebo-controlled, German Phase IIa hdmASIT-001 trial evaluating subcutaneous hdm-ASIT+....